174 related articles for article (PubMed ID: 9287259)
1. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
Mahapatra SN; Hackett D
Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice.
Trick L; Stanley N; Rigney U; Hindmarch I
J Psychopharmacol; 2004 Jun; 18(2):205-14. PubMed ID: 15260909
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
5. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
8. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
Samuelian JC; Hackett D
J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
[TBL] [Abstract][Full Text] [Related]
10. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients.
Rahman MK; Akhtar MJ; Savla NC; Sharma RR; Kellett JM; Ashford JJ
Br J Clin Pract; 1991; 45(4):255-8. PubMed ID: 1810358
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
13. Prescribing of venlafaxine and dosulepin in primary care.
McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
[No Abstract] [Full Text] [Related]
14. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
15. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
Simon JS; Aguiar LM; Kunz NR; Lei D
J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
Mbaya P
Hum Psychopharmacol; 2002 Oct; 17(7):335-9. PubMed ID: 12415551
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
Bukh JD; Jørgensen MB; Dam H; Plenge P
Nord J Psychiatry; 2009; 63(4):347-51. PubMed ID: 19347769
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
Shrivastava RK; Cohn C; Crowder J; Davidson J; Dunner D; Feighner J; Kiev A; Patrick R
J Clin Psychopharmacol; 1994 Oct; 14(5):322-9. PubMed ID: 7806687
[TBL] [Abstract][Full Text] [Related]
20. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
